MKI67 and melanoma: An increase in Ki67 expression was observed in CD8+ T cells among melanoma patients (p < 0.05) who received anti-PD-1 treatment, mostly in the PD-1+CD8+T subgroup (p < 0.05), indicating the presence of an immune response before treatment [84].